left, the unpublished structure of apo SARS2 PLpro (pdb 6wrh, 1.6 Å, determined by the Centre for Structural Genomics of Infectious Disease (CSGID)) is coloured in analogy with Figs
1E and
EV1, indicating Thumb, Fingers and Palm subdomain. The PLpro fold forms an open right hand that holds the ubiquitin fold, guiding its C‐terminus into the active site. PLpro contains an N‐terminal Ubl domain of unknown function, and this domain can vary in orientation. The high‐resolution structure was generated with a catalytic Cys to Ser mutation; a more common catalytic Cys to Ala mutant destabilises PLpro (Fig
EV3D).
Middle, structure of SARS2 PLpro bound to ubiquitin (orange, covered by a semi‐transparent surface).
Right, structure of SARS2 PLpro bound to the C‐terminal domain of ISG15 (ISG15
CTD, salmon, under a semi‐transparent surface). Also see Fig
1. In ubiquitin and ISG15
CTD complexes, propargylamide‐based suicide probes (Ekkebus
et al,
2013) covalently modify catalytic Cys111.